Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values

Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify di...

Full description

Saved in:
Bibliographic Details
Published in:Current medical science 2021-10, Vol.41 (5), p.916-929
Main Authors: Li, Mi, Cheng, Wei-ting, Li, Hao, Zhang, Zhi, Lu, Xiao-li, Deng, Si-si, Li, Jian, Yang, Cai-hong
Format: Article
Language:English
Subjects:
Biomarkers, Tumor - genetics
Bone Neoplasms - drug therapy
Bone Neoplasms - genetics
Bone Neoplasms - surgery
Computational Biology - methods
Databases, Genetic
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Regulatory Networks
Humans
Medicine
Medicine & Public Health
Neoadjuvant Therapy
Osteosarcoma - drug therapy
Osteosarcoma - genetics
Osteosarcoma - surgery
Prognosis
RNA, Long Noncoding - genetics
Survival Analysis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Osteosarcoma is one of the most common types of bone sarcoma with a poor prognosis. However, identifying the predictive factors that contribute to the response to neoadjuvant chemotherapy remains a significant challenge. Methods A public data series (GSE87437) was downloaded to identify differentially expressed genes (DEGs) and differentially expressed lncRNAs (DElncRNAs) between osteosarcoma patients that do and do not respond to preoperative chemotherapy. Subsequently, functional analysis of the transcriptome expression profile, regulatory networks of DEGs and DElncRNAs, competing endogenous RNAs (ceRNA) and protein-protein interaction networks were performed. Furthermore, the function, pathway, and survival analysis of hub genes was performed and drug and disease relationship prediction of DElncRNA was carried out. Results A total of 626 DEGs, 26 DElncRNAs, and 18 hub genes were identified. However, only one gene and two lncRNAs were found to be suitable as candidate gene and lncRNAs respectively. Conclusion The DEGs, hub genes, candidate gene, and candidate lncRNAs screened out in this context were considered as potential biomarkers for the response to neoadjuvant chemotherapy of osteosarcoma.
ISSN:2096-5230
2523-899X
DOI:10.1007/s11596-021-2430-2